Nyxoah (NYXH) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $1.48 (-0.67%), Market cap $0.13B, 52-week low–high $2.79 ~ $8.28.
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Financial statements, price targets, institutional (13F) holdings and related news for Nyxoah are updated in real time on BlackAll Trade.
Nyxoah trades at $1.48 (-0.67%). Real-time quotes and charts are available on BlackAll Trade.
Nyxoah has a market cap of about $0.13B.
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimu